Mu-opioid receptor alleviated ferroptosis in hepatic ischemia-reperfusion injury via the HIF-1α/ KCNQ1OT1 axis
American Journal of Physiology-Cell Physiology · 2023
DOI: 10.1152/ajpcell.00394.2022 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2023. Verfasst von Shuangfa Zou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Hunan Cancer Hospital, Changsha, China. Hauptthemen laut MEDLINE: Ferroptosis, Hypoxia-Inducible Factor 1, alpha Subunit, Receptors, Opioid, mu, Reperfusion Injury. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Hunan Cancer Hospital, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Ferroptosis is the ideal therapeutic target for hepatic ischemia and reperfusion injury (HIRI). The μ opioid receptor (MOR) is associated with ferroptosis in HIRI. We aimed to determine the ferroptosis-related therapeutic mechanism of MOR in HIRI. A model of HIRI was established in BALB/c mice. Primary hepatocytes isolated from mice were stimulated by hypoxia/reoxygenation (H/R). Changes in histopathology were determined by H&E staining. Alterations in ferroptosis were evaluated by malondialdehyde (MDA), iron, glutathione (GSH), ACSL4, GPX4, and mitochondrial morphology. ALT and AST were used to determine hepatic function. First, we found that hepatic ischemia/reperfusion (I/R) induced the destruction of hepatic tissue structure and dead hepatocytes and determined that ferroptosis occurred in vivo and in vitro. During HIRI, the expression levels of HIF-1α and KCNQ1OT1 were significantly upregulated. We demonstrated that sufentanil improved the damage in the liver and hepatocytes undergoing I/R. Importantly, sufentanil inhibited ferroptosis in HIRI. In addition, sufentanil downregulated the expression levels of HIF-1α and KCNQ1OT1 in HIRI. Increases in HIF-1α and KCNQ1OT1 reversed the role of sufentanil in ferroptosis and HIRI. Subsequently, we determined that HIF-1α could activate the transcription of KCNQ1OT1 by binding to its promoter. In addition, KCNQ1OT1 was demonstrated to enhance ACSL4 stability by interacting with SRSF1. Finally, we observed that KCNQ1OT1 downregulation protected hepatocytes from hepatic I/R and inhibited ferroptosis. KCNQ1OT1 upregulation aggravated ferroptosis and hepatic injury during I/R. However, decreases in ACSL4 and SRSF1 reversed the harmful role of KCNQ1OT1 upregulation in HIRI. MOR alleviated ferroptosis in HIRI via the HIF-1α/ KCNQ1OT1 axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Hunan Cancer Hospital, Changsha, China.
ORCID-Profile: Jinfeng Yang
Förderung
- Hunan Cancer Hospital
- Natural Science Foundation of Hunan Province
Zitieren
APA
Zou, S., Sun, H., Peng, Y., Liang, C., Zheng, C., Wang, L., & Yang, J. (2023). Mu-opioid receptor alleviated ferroptosis in hepatic ischemia-reperfusion injury via the HIF-1α/ KCNQ1OT1 axis. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00394.2022
Vancouver
Zou S, Sun H, Peng Y, Liang C, Zheng C, Wang L, et al. Mu-opioid receptor alleviated ferroptosis in hepatic ischemia-reperfusion injury via the HIF-1α/ KCNQ1OT1 axis. American Journal of Physiology-Cell Physiology. 2023. doi:10.1152/ajpcell.00394.2022
BibTeX
@article{Zou2023,
author = {Zou, Shuangfa and Sun, Huiping and Peng, Yanhua and Liang, Canxin and Zheng, Chumei and Wang, Lijuan and Yang, Jinfeng},
title = {Mu-opioid receptor alleviated ferroptosis in hepatic ischemia-reperfusion injury via the HIF-1α/ KCNQ1OT1 axis},
journal = {American Journal of Physiology-Cell Physiology},
year = {2023},
doi = {10.1152/ajpcell.00394.2022}
}
EUVIMED